Correlation of serum levels of interleukin-1 family members with disease activity and response to treatment in hairy cell leukemia

European Cytokine Network

Volumn 9, Issue 1, 1998, Pages 33-39

  Barak, Vivian ^a   Nisman, Benjamin ^a   Polliack, Aaron ^a   Vannier, Edouard ^b   Dinarello, Charles A ^c  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b TUFTS MEDICAL CENTER   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

2 CDA; HCL; IL 1; IL 1Ra; IL 1sRI; IL 1sRII; Response

Indexed keywords

CLADRIBINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA;

ARTICLE; BLOOD LEVEL; CANCER REGRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; HAIRY CELL LEUKEMIA; HUMAN; IMMUNOREGULATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; LYMPHOPROLIFERATIVE DISEASE;

2-CHLOROADENOSINE; ANTIMETABOLITES, ANTINEOPLASTIC; DEOXYADENOSINES; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; LEUKEMIA, HAIRY CELL; RECEPTORS, INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-1 TYPE II; SEVERITY OF ILLNESS INDEX; SIALOGLYCOPROTEINS;

EID: 0031961101     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Burthem J, Cawley J C. 1996. Hairy cell leukaemia. Springer-Verlag. Berlin, Heidelberg, New York.
2. Jansen J, LeBien T W, Kersey J H. 1982. The phenotype of the neoplastic cells of hairy cell leukemia studied with monoclonal antibodies. Blood 59: 609.
3. Korsmeyer S J, Greene W C, Waldmann T A. 1984. Cellular origin of hairy cell leukemia: malignant B cells that express receptors for T cell growth factor. Sem. Oncol. 11: 394.
4. Schmid M, Porzsolt F. 1995. Autocrine and paracrine regulation of neoplastic cell growth in hairy cell leukemia. (Review) Leuk. Lymphoma 17: 401.
5. Till K J, Cawley J C. 1994. Accessory cells mediate hairy-cell proliferation by mechanism(s) involving both adhesion and TNF-alpha secretion. Br. J. Haematol. 87: 687.
6. Schmid M, Schrezenmeier H, Staib G, Porzsolt F. 1995. Evidence for a paracrine pathway of B cell stimulation in hairy cell leukaemia. Br. J. Haematol. 90: 156.
7. Trentin L, Zambello R, Pizzolo G, Vinante F, Ambrosetti A, Chisesi T, and al. 1991. Tumor necrosis factor-alpha and B cell growth factor induce leukemic hairy cells to proliferate in vitro. Cancer Detect. Prev. 15: 385.
8. Schiller J H, Bittner G, Spriggs D R. 1992. Tumor necrosis factor, but not other hematopoietic growth factors, prolongs the survival of hairy cell leukemia cells. Leuk. Res. 16: 337.
9. Lauria F, Raspadori D, Benfenati D, Rondelli D, Pallotti A, Tura S. 1992. Biological markers and minimal residual disease in hairy cell leukemia. Leukemia 6 (suppl. 4): 149.
10. Romquin N, Billard C. 1995. Autocrine loop of tumor necrosis factor induced by interferon-alpha in tumor cells from hairy cell leukemia. Leukemia 9: 87.
11. Schuler M, Huber C, Peschel C. 1995. Cytokines in the pathophysiology and treatment of chronic B cell malignancies. A review. Ann. Hematol. 71: 57.
12. Digel W, Porzsolt F, Schmid M, Herrmann F, Lesslauer W, Brockhaus M. 1992. High levels of circulating soluble receptors for tumor necrosis factor in hairy cell leukemia and type B chronic lymphocytic leukemia. J. Clin. Invest. 89: 1690.
13. Foa R, Guarini A, Francia di Celle P, Trentin L, Gillio-Tos A, Bellone G, Carbone A, Attisano C, Massaia M, Raspadori D. 1992. Constitutive production of tumor necrosis factor-alpha in hairy cell leukemia: possible role in the pathogenesis of the cytopenia(s) and effect of treatment with interferon-alpha. J. Clin. Onc. 10: 954.
14. Barak V, Ginzburg M, Kalickman I, Polliack A. 1992. Serum soluble IL-2 receptor levels are associated with clinical disease status and histopathological grade in non Hodgkin's lymphoma and chronic lymphocytic leukemia. Leuk. Lymphoma 7: 431.
15. Barak V, Nisman B, Dann E J, Kalickman I, Ruchlemer R, Bennett M A, Polliack A. 1994. Serum interleukin-1β levels as a marker in hairy cell leukemia: correlation with disease status and sIL-2R levels. Leuk. Lymphoma 14: 33.
16. Griffiths S D, Cowley J C. 1990. The effect of cytokines, including IL-1, IL-4 and IL-6 in hairy cell proliferation/differentiation. Leukemia 4: 337.
17. Barut B A, Cochran M K, O'Hara C, Anderson K C. 1990. Response patterns of hairy cell leukemia to B cell mitogens and growth factors. Blood 76: 2091.
18. Dinarello CA. 1994. The interleukin-1 family: 10 years of discovery (Review). FASEB J. 8: 1314.
19. Greenfeder S A, Nunes P, Kwee L, Labow M, Chizzonite R A, Ju G. 1995. Molecular cloning and characterization of a second subunit of the interleukin-1 receptor complex. J. Biol. Chem. 270: 13757.
20. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, Giri J G, Dower S K, Sims J E, Mantovani A. 1993. Interleukin-1 type 11 receptor: a "decoy" target for IL-1 that is regulated by IL-4. Science 261: 472.
21. Juliusson G, Liliemark J. 1992. Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2′-deoxyadenosine (CdA): relation to opportunistic infections. Blood 79: 888.
22. Piro L D, Carrera C J, Carson D A, Beutler E. 1990. Lasting remissions in hairy cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N. Engl. J. Med. 322: 1117.
23. Piro L D. 1992. 2-chlorodeoxyadenosine treatment of lymphoid malignancies. Blood 79: 843.
24. Annino L, Ferrari A, Giona F, Cimino G, Crescenzi S, Cava M C, Pacchiarotti A, Mandelli F. 1994. Deoxycoformycin induces long-lasting remissions in hairy cell leukemia: clinical and biological results of two different regimens. Leuk. Lymphoma 14 (suppl. 1): 115.
25. Dann E J, Gillis E A, Rachmilewitz E A, Barak V, Cass Y, Ruchlemer R, Polliack A. 1994. Hairy cell leukemia: results of 2-chlorodeoxyadenosine therapy in Jerusalem. Leuk. Lymphoma 14 (suppl. 1): 127.
26. Lonnemann G, Endres S, van der Meer J W, Cannon J G, Dinarello C A. 1988. A radioimmunoassay for human interleukin-1α: measurement of IL-1α produced in vitro by human blood mononuclear cells stimulated with endotoxin. Lymphokine Rex. 7: 75.
27. Cimino G, Annino L, Giona F, Bellantuono P, Cava M C, Di Gregorio AO, Amadori S, Mandelli F. 1991. Variable sIL-2R, IL-1 beta and TNF-alpha serum levels in peripheral blood and bone marrow of patients with hairy cell leukemia. (Abstract). Proceedings of AACR 32: 193.
28. Barak V, Vannier E, Nisman B, Polliack A, Dinarello C A. 1996. Cytokines and their soluble receptors as markers for hairy cell leukemia. (Abstract). Eur. Cytokine Netw. 7: 536.
29. Gin J G, Newton R C, Horuk R. 1990. Identification of soluble interleukin-1 binding protein in cell-free supernatants. Evidence for soluble interleukin-1 receptor. J. Biol. Chem. 265: 17416.
30. Symons J A, Eastgate J A, Duff G W. 1991. Purification and characterization of a novel soluble receptor for interleukin-1. J. Exp. Med. 174: 1251.
31. Pruitt J H, Welborn M B, Edwards P D, Harward T R, Seeger J W, Martin T D, Smith C, Kenney J A, Wesdrop R I, Meijer S, Cuest M A, Abouhanze A, Copeland E M 3d, Giri J, Sims J E, Moldawer L L, Oldenburg H S. 1996. Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome. Blood 87: 3282.
32. Van der Poll T, de Waal Malefyt R, Coyle S M, Lowry S F. 1997. Anti-inflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, IL-13. J. Inf. Dis. 175: 118.
33. Van Deuren M, van der Ven-Jongerkrijg J, Vannier E, van Dalen R, Pesman G, Bartelink A K, Dinarello C A, van der Meer J W. 1997. The pattern of interleukin-1β (IL-1β) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections. Blood 90: 1101.
34. Whicher I T, Banks R E. 1995. Cytokines as tumor markers. (Review) Scand. J. Clin. Lab. Invest. 55 (suppl.) 221: 122.
35. Michiel D F, Oppenheim J J. 1992. Cytokines as positive and negative regulators of tumor promotion and progression. (Review) Sem. Cancer Biol. 3: 3.